I've no idea. Just guessing.
And, it isn't likely to be any of the big funds who would have strict rules about not investing in spec stocks pre-revenue.
"Sophos" more properly refers to high net worth individuals rather Instos (institutional investors).
Just shooting the breeze.
2024 BrainChip Discussion, page-6341
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $323.8M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 16.0¢ | $1.039M | 6.226M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 53 | 2389988 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 94290 | 7 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| BRN (ASX) Chart |